Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071.

Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071. Mol Cancer Ther. 2020 04; 19(4):1031-1039.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Female
Follow-Up Studies
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Male
Maximum Tolerated Dose
Melanoma
Middle Aged
Neoplasm Metastasis
Prognosis
Protein Kinase C
Pyrroles
Quinazolines
Tissue Distribution
Uveal Neoplasms
Young Adult